Targeting cancer with selective cbp/p300 bromodomain inhibitors

Jaleel, M; Senaiar, RS; Abbineni, C; Renukappa, GA; Mukherjee, S; Marappan, S; Samiulla, DS; Aravind, AB; Kumar, NR; Reddy, VSN; Babu, A; Srinivas, AP; Yadlapalli, P; Tgore, S; Raghavendra, NR; Naik, CD; Giri, S; Antony, T; Nellore, K; Chelur, S; Daginakatte, G; Ravanti, L; Myllymaki, M; Wohlfahrt, G; Mattila, E; Karlsson, S; Bjorkman, M; Riikonen, R; Ikonen, T; Leimu, L; Malmstrom, C; Korjamo, T; Moilanen, A; Ramachandra, M; Samajdar, S

CANCER RESEARCH, 2020; 80 (16):